Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,467 | 1,424 | 99.9% |
| Education | $20.15 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,870 | 181 | $0 (2024) |
| ABBVIE INC. | $1,568 | 108 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,455 | 85 | $0 (2024) |
| Lilly USA, LLC | $1,340 | 118 | $0 (2024) |
| Novo Nordisk Inc | $1,322 | 119 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,246 | 138 | $0 (2024) |
| GlaxoSmithKline, LLC. | $899.18 | 69 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $840.22 | 51 | $0 (2024) |
| Amgen Inc. | $811.02 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $759.09 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,006 | 124 | AstraZeneca Pharmaceuticals LP ($328.73) |
| 2023 | $2,178 | 142 | AbbVie Inc. ($358.49) |
| 2022 | $2,058 | 138 | Novo Nordisk Inc ($273.57) |
| 2021 | $1,960 | 133 | AbbVie Inc. ($537.97) |
| 2020 | $2,367 | 182 | Teva Pharmaceuticals USA, Inc. ($290.45) |
| 2019 | $2,939 | 246 | PFIZER INC. ($456.22) |
| 2018 | $2,835 | 264 | PFIZER INC. ($458.63) |
| 2017 | $2,145 | 198 | PFIZER INC. ($312.97) |
All Payment Transactions
1,427 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Vaccines | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PAIN | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: PAIN | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Obesity | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: VACCINE | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 824 | 1,224 | $202,261 | $58,261 |
| 2022 | 10 | 719 | 1,044 | $160,291 | $40,630 |
| 2021 | 16 | 826 | 1,224 | $167,699 | $93,882 |
| 2020 | 20 | 921 | 1,266 | $159,459 | $77,362 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 539 | $94,325 | $17,224 | 18.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $29,260 | $12,442 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 183 | 183 | $37,149 | $8,364 | 22.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 90 | 90 | $6,030 | $5,909 | 98.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 84 | $6,300 | $3,874 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 115 | $14,445 | $3,855 | 26.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 93 | 93 | $4,092 | $2,730 | 66.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,640 | $1,641 | 62.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 45 | 45 | $1,980 | $1,321 | 66.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 20 | $6,040 | $900.10 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 515 | $84,895 | $16,603 | 19.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 188 | 188 | $38,164 | $8,838 | 23.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 74 | 74 | $4,958 | $4,793 | 96.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 113 | $14,184 | $3,803 | 26.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 76 | 76 | $3,344 | $2,096 | 62.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,640 | $1,680 | 63.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 23 | $6,946 | $1,400 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $3,072 | $720.63 | 23.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $1,100 | $521.47 | 47.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 19 | $988.00 | $173.09 | 17.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 227 | 558 | $87,606 | $45,710 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 172 | 172 | $34,916 | $22,130 | 63.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 130 | $13,780 | $7,477 | 54.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 84 | 84 | $5,628 | $5,482 | 97.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 28 | $5,880 | $3,635 | 61.8% |
About Dr. Dennis Carson, MD
Dr. Dennis Carson, MD is a Family Medicine healthcare provider based in Elyria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982816294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dennis Carson, MD has received a total of $18,487 in payments from pharmaceutical and medical device companies, with $2,006 received in 2024. These payments were reported across 1,427 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($18,467).
As a Medicare-enrolled provider, Carson has provided services to 3,290 Medicare beneficiaries, totaling 4,758 services with total Medicare billing of $270,135. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Elyria, OH
- Active Since 05/07/2007
- Last Updated 12/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982816294
Products in Payments
- FARXIGA (Drug) $961.09
- CHANTIX (Drug) $777.33
- JARDIANCE (Drug) $755.30
- JANUVIA (Drug) $744.56
- VRAYLAR (Drug) $643.73
- UBRELVY (Drug) $625.03
- ELIQUIS (Drug) $594.27
- XARELTO (Drug) $580.82
- XIFAXAN (Drug) $558.76
- Ozempic (Drug) $452.88
- TRELEGY ELLIPTA (Drug) $421.05
- NURTEC ODT (Drug) $389.17
- Vascepa (Drug) $375.78
- AJOVY (Biological) $357.63
- EMGALITY (Drug) $355.91
- Aimovig (Biological) $312.53
- Prolia (Biological) $268.70
- BREZTRI (Drug) $260.23
- REXULTI (Drug) $260.18
- TRULICITY (Drug) $255.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Elyria
Dr. Bradley Barker, Md, MD
Family Medicine — Payments: $17,492
Nicholas Ksenich, Md, MD
Family Medicine — Payments: $13,844
Jack Cramer, Do, DO
Family Medicine — Payments: $9,022
Abraham Pedro, Md, MD
Family Medicine — Payments: $4,907
Chuka Onyeneke, M.d, M.D
Family Medicine — Payments: $1,291
Matthew Cohen, Do, DO
Family Medicine — Payments: $157.27